Rating Agencies

Share recommendations

Made with ❤ von BGFL

#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

Last 24H

Today

Yesterday

7 days

All

All Issuers BankM AG GBC AG Montega AG

19.11.2025 11:00AM

Study issued by GBC AG

SMARTBROKER HOLDING AG (von GBC AG): BUY

BUY

Company Name: SMARTBROKER HOLDING AG ISIN: DE000A2GS609 Reason for the research: Research Report (Initial Coverage) Recommendation: BUY Target price: 17.50 EUR Target price on sight of: 31.12.2026 Last rating change: Analyst: Matthias Greiffenberger, Cosmin Filker, Niklas Ripplinger Their hybrid business model combining media [ … ]

Original Research

DE000A2GS609 A2GS60

Smartbroker Holding

14.05.2024 10:01AM

Study issued by GBC AG

A.H.T. Syngas Technology N.V. (von GBC AG): BUY

BUY

- Growth strategy to become a multinational CleanTec and clean energy providers - Financial year 2023 successfully concluded with record sales, record earnings and a promising backlog according to preliminary figures AHT Syngas Technology N.V. (AHT) is a global company that develops technologies for converting carbon-based fuels into synth [ … ]

Original Research

NL0010872388 A12AGY

AHT Syngas Technology

15.12.2023 09:31AM

Study issued by GBC AG

HAEMATO AG (von GBC AG): suspended

suspended

Delisting of the HAEMATO share to take place from February 2023; price potential not yet exhausted; GBC-rating and GBC-price target suspended HAEMATO has announced the termination of the inclusion of the shares in the open market of 30 November 2023. The shares are to be delisted after expiry of the notice period, at the latest by the end [ … ]

Original Research

DE000A289VV1 A289VV

Haemato

31.03.2022 11:02AM

Study issued by GBC AG

Bitcoin Group SE (von GBC AG): BUY

BUY

Preliminary business figures 2021 - Very good development with results above our forecasts On March 29, 2022, Bitcoin Group SE published the preliminary business figures for the year 2021. Accordingly, sales increased by 56.6% to EUR23.5 million (previous year: EUR15.0 million). EBITDA increased by 85.7% to EUR19.5 million (previous year: EUR10. [ … ]

Original Research

DE000A1TNV91 A1TNV9

Bitcoin Group

10.12.2021 12:31PM

Study issued by GBC AG

HAEMATO AG (von GBC AG): Management Interview

Management Interview

In operational terms, HAEMATO AG is heading for a record year following the acquisition of M1 Aesthetics GmbH. In addition, the expansion of their private label business is increasingly coming into focus. In this regard, the company plans to expand its portfolio with a botulinum toxin product under its own brand. GBC analyst Cosmin Filker spoke wi [ … ]

Original Research

DE000A289VV1 A289VV

Haemato

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.

Rating Agencies